1. Claim 1: a formula compound (1),where Y is N or CH； R¹ is selected from the group consisting of straight or branched C₂₋₈ alkyl, saturated monocyclic C₃₋₈ cycloalkyl, oxetanyl, tetrahydrofuranyl, and tetrahydropyranyl； all of which may be substituted, one or more times, with one or more substituents selected from the group consisting of methyl, fluorine, hydroxy, cyano or methoxy； R² is selected from the group consisting of linear or branched C₁₋₈-alkyl, phenyl, benzo [1,3] dioxol, and saturated monocyclic C₃₋₈-cycloalkyl； or R² is phenyl substituted one or more times with one or more substituents selected from the group consisting of halogen, C₁₋₃-alkyl and methoxy；or R² is pyridine substituted with a substituent selected from the group consisting of halogen, C₁₋₃-alkyl,C₁₋₃ alkoxy,Hydrogen fluoride c83218c83183323；C₃₋₄ cycloalkoxy and C₄₋₅ methylcycloalkoxy；or R² is selected from the group consisting of C miembros-alkyl-substituted 5-membered heteroaryls；R³ is selected from the group consisting of C₁₋₃ alkyl and saturated monocyclic C₃₋₈ cycloalkyl； each of which may be optionally substituted with a substituent selected from halogen, C₁₋₃ alkoxy,1. Phenyl, propylamine and oxetano； and the contained taurine and pharmaceutically acceptable salts.Reivindicación 1: Un compuesto de fórmula (1), donde Y es N o CH； R¹ se selecciona del grupo que consiste en alquilo C₂₋₈ lineal o ramificado, cicloalquilo C₃₋₈ monocíclico saturado, oxetanilo, tetrahidrofuranilo y tetrahidropiranilo； todos los cuales pueden estar sustituidos, una o más veces, con uno o más sustituyentes seleccionados del grupo consistente en metilo, flúor, hidroxi, ciano o metoxi； R² se selecciona del grupo consistente en alquilo C₁₋₈ lineal o ramificado, fenilo, benzo[1,3]dioxol y cicloalquilo C₃₋₈ monocíclico saturado； o R² es fenilo sustituido una o más veces con uno o más sustituyentes seleccionados del grupo consistente en halógeno, alquilo C₁₋₃ y metoxi； o R² es piridina sustituida con un sustituye
